The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

ARICEPT EVESS 5 mg orodispersible tablet

Pfizer Healthcare IrelandPA0822/002/003

Main Information

Trade NameARICEPT EVESS 5 mg orodispersible tablet
Active SubstancesDonepezil hydrochloride
Dosage FormOrodispersible tablet
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/002/003

Group Information

ATC CodeN06DA Anticholinesterases
N06DA02 donepezil


Licence Issued02/06/2006
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0062-001-015
Interchangeable List DocumentPDF of Interchangeable List
« Back